|
This two-part special features a panel comprised of members of Congress, a pharmaceutical industry expert, a physician, a researcher running clinical trials on Alzheimer’s, and a CEO of a Health Center serving the uninsured and underinsured. The panel considers a variety of topics including the advances in science and what new medicines are in the pipeline, the length of time involved as well as the process behind bringing a drug to market, the financial impact of the industry to the state, the role of the FDA, and the high cost of medications that many consumers are unable to afford.
Tape Piece: - The two-part special begins with a mini-documentary produced by Joanna Caplan. This segment features researcher Dr. James Goydos and Dr. Susan Goodin at The Cancer Institute of New Jersey who have found a revolutionary approach to treat the deadly cancer Melanoma using a drug currently approved to treat symptoms of ALS. As this drug nears the final approval phase, it promises new hope for patients and their families who have been affected by this terrible disease. We will go into the lab, talk with the researcher and doctor conducting the clinical trial about this exciting new research, the hurdles they face and what it could mean to patients.
Congressman-elect Leonard Lance
|
Bob Franks
|
Eva Turbiner |
Dr. Karen Bell
|
Guests:
Part 1
Congressman-elect Leonard Lance – Representing New Jersey’s the 7th district, who will begin his first term as a U.S. Congressman in January.
Bob Franks – President of the HealthCare Institute of New Jersey.
Dr. Karen Bell – Associate Clinical Professor of Neurology, and Director of the Alzheimer’s Disease Clinical Trials at Columbia University Medical Center.
Eva Turbiner – President and CEO of the Zufall Health Center in Dover, New Jersey.
Part 2
Kendell Sprott – Acting Chair Department of Pediatrics at UMDNJ/NJ Medical School
Bob Franks – President of the HealthCare Institute of New Jersey.
Dr. Karen Bell – Associate Clinical Professor of Neurology, and Director of the Alzheimer’s Disease Clinical Trials at Columbia University Medical Center.
Eva Turbiner – President and CEO of the Zufall Health Center in Dover, New Jersey.
|
